Novadaq Technologies Inc. (TSE:NDQ)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a research report issued to clients and investors on Tuesday. They presently have a C$17.00 price objective on the stock.

Separately, Royal Bank Of Canada reiterated an “outperform” rating on shares of Novadaq Technologies in a research report on Thursday, July 7th.

Shares of Novadaq Technologies (TSE:NDQ) opened at 15.94 on Tuesday. The company’s market capitalization is $915.51 million. The firm has a 50-day moving average of $15.17 and a 200 day moving average of $13.77. Novadaq Technologies has a 1-year low of $10.81 and a 1-year high of $20.40.

Novadaq Technologies Company Profile

Novadaq Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.